2018•Multiple Sclerosis and Related DisordersRequires access

In Clarity the Severity and Frequency of Relapses are Lower in Patients with Relapsing-remitting Multiple Sclerosis Treated with Cladribine Tablets Versus Placebo

Sven Schippling, Maria Pia Sormani, Nicola De Stefano, Gavin Giovannoni, Andrew Galazka, Birgit Keller, Nektaria Alexandri

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Cladribine, Relapsing remitting, Medicine, Multiple sclerosis, Placebo, Post-hoc analysis, Internal medicine, CLARITY

Back to paper search Browse research topics Original source

In Clarity the Severity and Frequency of Relapses are Lower in Patients with Relapsing-remitting Multiple Sclerosis Treated with Cladribine Tablets Versus Placebo — Research Paper | ScholarLens